These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9725372)

  • 1. Integrilin prevents prolonged bleeding times after cardiopulmonary bypass.
    Suzuki Y; Hillyer P; Miyamoto S; Niewiarowski S; Sun L; Rao AK; Hollenbach S; Edmunds LH
    Ann Thorac Surg; 1998 Aug; 66(2):373-81. PubMed ID: 9725372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet anesthesia with nitric oxide with or without eptifibatide during cardiopulmonary bypass in baboons.
    Suzuki Y; Malekan R; Hanson CW; Niewiarowski S; Sun L; Rao AK; Edmunds LH
    J Thorac Cardiovasc Surg; 1999 May; 117(5):987-93. PubMed ID: 10220694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tirofiban provides "platelet anesthesia" during cardiopulmonary bypass in baboons.
    Hiramatsu Y; Gikakis N; Anderson HL; Gorman JH; Marcinkiewicz C; Gould RJ; Niewiarowski S; Edmunds LH
    J Thorac Cardiovasc Surg; 1997 Jan; 113(1):182-93. PubMed ID: 9011688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enoxaparin suppresses thrombin formation and activity during cardiopulmonary bypass in baboons.
    Gikakis N; Rao AK; Miyamoto S; Gorman JH; Khan MM; Anderson HL; Hack CE; Sun L; Niewiarowski S; Colman RW; Edmunds LH
    J Thorac Cardiovasc Surg; 1998 Dec; 116(6):1043-51. PubMed ID: 9832697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: a pilot clinical study.
    Chung A; Wildhirt SM; Wang S; Koshal A; Radomski MW
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):782-90. PubMed ID: 15821644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass.
    Gorman RC; Ziats N; Rao AK; Gikakis N; Sun L; Khan MM; Stenach N; Sapatnekar S; Chouhan V; Gorman JH; Niewiarowski S; Colman RW; Anderson JM; Edmunds LH
    J Thorac Cardiovasc Surg; 1996 Jan; 111(1):1-11; discussion 11-2. PubMed ID: 8551753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet preservation with a glycoprotein IIb/IIIa inhibitor in a porcine cardiopulmonary bypass model.
    Kondo N; Suzuki Y; Wakayama F; Tamai Y; Ji K; Fukui K; Fukuda I
    Ann Thorac Surg; 2005 Jul; 80(1):251-7. PubMed ID: 15975376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators.
    Ohman EM; Kleiman NS; Gacioch G; Worley SJ; Navetta FI; Talley JD; Anderson HV; Ellis SG; Cohen MD; Spriggs D; Miller M; Kereiakes D; Yakubov S; Kitt MM; Sigmon KN; Califf RM; Krucoff MW; Topol EJ
    Circulation; 1997 Feb; 95(4):846-54. PubMed ID: 9054741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iloprost and echistatin protect platelets during simulated extracorporeal circulation.
    Bernabei A; Gikakis N; Kowalska MA; Niewiarowski S; Edmunds LH
    Ann Thorac Surg; 1995 Jan; 59(1):149-53. PubMed ID: 7529485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of heparin-induced thrombocytopenia during open heart surgery with iloprost (ZK36374).
    Addonizio VP; Fisher CA; Kappa JR; Ellison N
    Surgery; 1987 Nov; 102(5):796-807. PubMed ID: 2445042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative platelet inhibition with eptifibatide during coronary artery bypass grafting with cardiopulmonary bypass.
    Dyke CM; Jennings LK; Maier G; Andreou C; Daly R; Tamberella MR
    J Cardiovasc Pharmacol Ther; 2007 Mar; 12(1):54-60. PubMed ID: 17495258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacology of eptifibatide.
    Phillips DR; Scarborough RM
    Am J Cardiol; 1997 Aug; 80(4A):11B-20B. PubMed ID: 9291241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nafamostat mesilate and minimal-dose aprotinin on blood-foreign surface interactions in cardiopulmonary bypass.
    Kaminishi Y; Hiramatsu Y; Watanabe Y; Yoshimura Y; Sakakibara Y
    Ann Thorac Surg; 2004 Feb; 77(2):644-50. PubMed ID: 14759453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraoperative management of patients with heparin-induced thrombocytopenia.
    Kappa JR; Fisher CA; Todd B; Stenach N; Bell P; Campbell F; Ellison N; Addonizio VP
    Ann Thorac Surg; 1990 May; 49(5):714-22; discussion 723. PubMed ID: 1692679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of nitric oxide gas on platelets during open heart operations.
    Mellgren K; Mellgren G; Lundin S; Wennmalm A; Wadenvik H
    Ann Thorac Surg; 1998 May; 65(5):1335-41. PubMed ID: 9594863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A baboon model for hematologic studies of cardiopulmonary bypass.
    Hiramatsu Y; Gikakis N; Gorman JH; Khan MM; Hack CE; Velthuis HT; Sun L; Marcinkiewicz C; Rao AK; Niewiarowski S; Colman RW; Edmunds LH; Anderson HL
    J Lab Clin Med; 1997 Oct; 130(4):412-20. PubMed ID: 9358080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of FK633, an ultra-short acting glycoprotein IIb/IIIa antagonist on platelet preservation during and after cardiopulmonary bypass.
    Tabata S; Yamaguchi S; Nagamine H; Tomita S; Arai S; Takemura H; Watanabe G
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):289-93. PubMed ID: 15296885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of glycoprotein IIb-IIIa inhibitors: A heart surgeon's perspective.
    Dyke CM
    Am Heart J; 1999 Oct; 138(4 Pt 2):307-16. PubMed ID: 10502236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
    Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic use of intravenous eptifibatide in patients undergoing percutaneous coronary intervention: acute coronary syndromes and elective stenting.
    Granada JF; Kleiman NS
    Am J Cardiovasc Drugs; 2004; 4(1):31-41. PubMed ID: 14967064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.